Depomed Inc (DEPO): Starboard Value Blasts The Company’s Board, Hires Special Advisors

Page 32 of 32

Page 32 of 32 – SEC Filing
SIGNATURES
After reasonable inquiry and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.
Dated:  July 27, 2016
STARBOARD VALUE AND OPPORTUNITY MASTER FUND LTD
By: Starboard Value LP,
       its investment manager
STARBOARD VALUE AND OPPORTUNITY S LLC
By: Starboard Value LP,
       its manager
STARBOARD VALUE AND OPPORTUNITY C LP
By: Starboard Value R LP,
       its general partner
STARBOARD VALUE R LP
By: Starboard Value R GP LLC,
       its general partner
STARBOARD VALUE LP
By: Starboard Value GP LLC,
       its general partner
 
STARBOARD VALUE GP LLC
By: Starboard Principal Co LP,
       its member
STARBOARD PRINCIPAL CO LP
By: Starboard Principal Co GP LLC,
       its general partner
STARBOARD PRINCIPAL CO GP LLC
STARBOARD VALUE R GP LLC
 
 
By:
/s/ Jeffrey C. Smith
 
Name:
Jeffrey C. Smith
 
Title:
Authorized Signatory
 
 
/s/ Jeffrey C. Smith
JEFFREY C. SMITH
Individually and as attorney-in-fact for Mark R. Mitchell, Peter A. Feld, Gavin T. Molinelli, John J. Delucca, James P. Fogarty, Peter A. Lankau, Mary K. Pendergast, Robert G. Savage and James L. Tyree

Follow Assertio Therapeutics Inc (NASDAQ:ASRT)

Page 32 of 32